Use of subcutaneous immunoglobulin in stiff person syndrome: Case series

INTRODUCTION: Intravenous immunoglobulin (IVIG) has been shown to be effective for the treatment of stiff person syndrome (SPS). However, some patients might not tolerate it. We report the tolerability profile of subcutaneous immunoglobulin (SCIg) in patients with SPS who did not tolerate IVIG. To o...

Descripción completa

Detalles Bibliográficos
Autores principales: Aljarallah, Salman, Newsome, Scott D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281948/
https://www.ncbi.nlm.nih.gov/pubmed/33761724
http://dx.doi.org/10.1097/MD.0000000000025260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281948/
https://www.ncbi.nlm.nih.gov/pubmed/33761724
http://dx.doi.org/10.1097/MD.0000000000025260

Ejemplares similares